Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease-Reference-Cited by-同舟云学术

Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease

Published:2017-09-19 Issue:12 Volume:136 Page:1102-1113
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Krishnan Prakash¹,Faries Peter¹,Niazi Khusrow¹,Jain Ash¹,Sachar Ravish¹,Bachinsky William B.¹,Cardenas Joseph¹,Werner Martin¹,Brodmann Marianne¹,Mustapha J. A.¹,Mena-Hurtado Carlos¹,Jaff Michael R.¹,Holden Andrew H.¹,Lyden Sean P.¹,Mewissen Mark,Katzen Barry,Nanjundappa Aravinda,Khuddus Matheen A.,Ricci Jason,Fry Dennis,Shishehbor Mehdi,Bosarge Christopher,Kovach Richard,Goodwin Mark,Raja Mohammad Laiq,Mayeda Guy,Sandhu Jasvinder,Rosales Oscar,Crowder William,Paolini David,Henretta John,Desai Pratik,Farhat Naim,Kang Edward,Ansel Gary,Ghani Mohammad,Miller William,Pollock Christopher,Korngold Ethan,Angle John F.,Schultz Greg,Gensler Todd,Lopez Louis,Park James,Al-Khoury Georges,Joels Charles,Metzger Christopher

Affiliation:

1. From Icahn School of Medicine at Mount Sinai, New York City (P.K., P.F.); Division of Cardiovascular Medicine, Emory University Hospital, Atlanta, GA (K.N.); Mission Cardiovascular Research Institute, Fremont, CA (A.J.); North Carolina Heart and Vascular, UNC-Rex Healthcare, Raleigh (R.S.); Pinnacle Health Cardiovascular Institute, Harrisburg, PA (W.B.B.); Yuma Cardiology Associates, Yuma Regional Medical Center, AZ (J.C.); Department of Angiology, Hanusch Hospital, Vienna, Austria (M.W.); Division...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference24 articles.

1. PERIPHERAL ARTERIAL DISEASE IN LARGE VESSELS IS EPIDEMIOLOGICALLY DISTINCT FROM SMALL VESSEL DISEASE

2. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

3. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II)

4. Nitinol Stent Implantation vs. Balloon Angioplasty for Lesions in the Superficial Femoral and Proximal Popliteal Arteries of Patients With Claudication: Three-Year Follow-up From the RESILIENT Randomized Trial

Cited by 173 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in the Treatment of Diabetic Foot Vascular Disease;Advances in Clinical Medicine;2024

2. Matched comparison of uncoated and paclitaxel-coated balloon angioplasty for isolated popliteal lesions excluding bail-out stenting;Cardiovascular Revascularization Medicine;2024-01

3. Sirolimus-Coated Balloon in Femoropopliteal Steno-Occlusive Disease: Efficacy, Safety, and 1-Year Outcomes. An All-Comers Registry;Journal of Endovascular Therapy;2023-12-12

4. Head-to-Head Comparison of 2 Paclitaxel-Coated Balloons for Femoropopliteal Lesions;JACC: Cardiovascular Interventions;2023-12

5. Midterm Results of Drug-Coated Balloon and Bare Metal Stent in the Treatment of TASCII C/D Femoropopliteal Artery Occlusive Disease: A Retrospective Multicenter Study;Journal of Endovascular Therapy;2023-11-18